Discuss the importance of vaccine safety in the context of mature immunization programs.
Identify the strengths and limitations of the many processes to ensure vaccines are very safe throughout a product lifecycle.
Continuing education credit will be available.
About Daniel Salmon, PhD, MPH:
During his tenure, he has led the expansion of the Institute’s website, a trusted resource for parents and professionals across the world. The site offers information on associations between potential adverse events and routine immunization in the United States. In addition to summarizing the scientific literature and providing causality assessments, the site links to supplemental information about specific adverse events. Before joining the Institute, Salmon was the Director of Vaccine Safety in the National Vaccine Program Office at the US Department of Health and Human Services. As director, he coordinated, evaluated and provided leadership for federal vaccine safety programs. During the 2009-10 H1N1 influenza pandemic, he oversaw the federal vaccine safety monitoring program—the most comprehensive vaccine safety monitoring effort in US history. Salmon’s work focuses on optimizing the prevention of childhood infectious diseases through the use of vaccines. He currently studies issues around post-licensure vaccine safety and the factors associated with parental decisions to vaccinate, or not vaccinate, their children. This work fits nicely with the Institute’s mission to provide an independent assessment of vaccines and vaccine safety to help guide decision makers and educate physicians, the public and the media about key issues surrounding the safety of vaccines.